PharVision Advisers’s AST SpaceMobile ASTS Stock Holding History

PharVision Advisers’s Portfolio ASTS Stock Details ASTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,640	Closed	-$541K	–	282
2024 Q4	$541K	Buy	+25,640	New	+$626K	0.46%	30

Other funds holding ASTS

Rakuten Group Setagaya-Ku, Tokyo, Japan $2.58B AUM 250.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BRIM

Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's ASTS Position: Q1 2025 in Review

PharVision Advisers sold out of AST SpaceMobile (ASTS) in Q1 2025, closing a stake of 25,640 shares — an estimated $541K sold.

PharVision Advisers first reported a position in ASTS in Q4 2024 and held it in 1 quarter. The position peaked at $541K in Q4 2024. 288 funds tracked by Wall St. Rank hold ASTS as of Q1 2025.

PharVision Advisers reported no remaining AST SpaceMobile position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 25,640 AST SpaceMobile shares in Q1 2025, an estimated $541K.
PharVision Advisers first reported a position in AST SpaceMobile in Q4 2024 and held it in 1 quarter.
PharVision Advisers's AST SpaceMobile position peaked at $541K in Q4 2024.
288 funds tracked by Wall St. Rank held AST SpaceMobile as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.